Anthony Mancini exercised Options for 9,363 Revolution Medicines shares at $33.62 each on 2026-09-10, while selling 15,448 shares across five transactions priced from $203.28 to $207.17. Investors can see the resulting ownership changes, including 43,890 shares and 96,746 derivative securities.
Key Highlights
- Anthony Mancini owned 59,338 Revolution Medicines shares after exercising the options.
- Five separate sales reduced his share ownership to 43,890 shares.
- His post-transaction derivative securities holding stood at 96,746, with the exercise representing about 8.8% of his prior position.
Revolution Medicines, Inc. (NASDAQ: RVMD) saw Anthony Mancini exercise options covering 9,363 shares at $33.62 per share on 10 September 2026. The transactions also included sales of company shares at prices ranging from $203.28 to $207.17 per share.
Option Exercise and Five Share Sales
After that exercise, Mancini owned 59,338 shares of Revolution Medicines, and the transaction represented about 15.8% of his resulting shareholding. Mancini sold a total of 15,448 shares through five separate transactions on the same date. Following those sales, his ownership stood at 43,890 shares. The exercise also involved 9,363 derivative securities. Mancini then held 96,746 derivative securities, with the transaction representing about 8.8% of his prior derivative securities holding.
FAQs
Q: How many Revolution Medicines shares did Anthony Mancini exercise?
A: Anthony Mancini exercised options for 9,363 Revolution Medicines shares. The exercise price was $33.62 per share, and the transaction occurred on 10 September 2026.
Q: How many RVMD shares did Anthony Mancini sell?
A: Anthony Mancini sold 15,448 Revolution Medicines shares across five transactions. The reported sale prices ranged from $203.28 to $207.17 per share.
Q: What was Anthony Mancini’s resulting Revolution Medicines shareholding?
A: After the option exercise, Anthony Mancini owned 59,338 Revolution Medicines shares. Following the reported sales, his shareholding was 43,890 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.